Italia markets close in 1 hour 9 minutes

AbbVie Inc. (ABBV)

NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
155,67+3,18 (+2,09%)
Al 10:21AM EDT. Mercato aperto.
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente152,49
Aperto153,90
Denaro154,29 x 900
Lettera154,33 x 800
Min-Max giorno153,35 - 155,86
Intervallo di 52 settimane105,56 - 175,91
Volume1.022.832
Media Volume7.345.593
Capitalizzazione275,086B
Beta (5 anni mensile)0,81
Rapporto PE (ttm)22,33
EPS (ttm)6,97
Prossima data utili28 lug 2022 - 01 ago 2022
Rendimento e dividendo (forward)5,64 (4,08%)
Data ex dividendo14 apr 2022
Stima target 1A163,01
  • GlobeNewswire

    Sirona Biochem Announces Exclusive Global Licensing Agreement with Allergan Aesthetics

    Licenses Revolutionary Skin Care Compound TFC-1067VANCOUVER, British Columbia, June 13, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) is pleased to announce it has entered into a global exclusive licensing agreement with Allergan Aesthetics, an AbbVie company (NYSE: ABBV), pursuant to which Allergan Aesthetics will develop and commercialize topical skin care treatments based on active ingredients derived from certain of Sirona’s patents for TFC-106

  • FX Empire

    Best Dividend Stocks to Buy Now for May 2022

    Markets have continued to be volatile for a while as inflation rages. In the past, dividend paying stocks have proven to be good hedges for these kinds of environments.

  • FX Empire

    Big Money Buying Up AbbVie

    AbbVie, Inc. (ABBV) stock has jumped in 2021, trailing the market thus far, but still rising decently at +17.1%. And the pharmaceutical giant could rise even more due to strong growth prospects. But another likely reason is Big Money lifting the stock.